drugset / Trial / NCT00068614
HER-2 Protein Vaccine in Treating Women With Breast Cancer
Open-labelTreatment
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of HER-2 protein vaccine in treating women who have breast cancer.
Timeline
- Start
- 2003-07
- Primary completion
- 2005-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AutoVac™ | Vaccine | — | Intramuscular |